Skip to main content

Kalosar Side Effects

Generic name: calcipotriene topical

Medically reviewed by Drugs.com. Last updated on Jan 7, 2024.

Note: This document contains side effect information about calcipotriene topical. Some dosage forms listed on this page may not apply to the brand name Kalosar.

Applies to calcipotriene topical: topical cream, topical foam, topical ointment, topical solution.

Serious side effects of Kalosar

Along with its needed effects, calcipotriene topical (the active ingredient contained in Kalosar) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking calcipotriene topical:

More common

Get emergency help immediately if any of the following symptoms of overdose occur while taking calcipotriene topical:

Symptoms of overdose

Other side effects of Kalosar

Some side effects of calcipotriene topical may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

Less common

Rare

For Healthcare Professionals

Applies to calcipotriene topical: topical cream, topical foam, topical kit, topical ointment, topical solution.

General

The most commonly reported side effects were burning, stinging, tingling, and skin irritation.[Ref]

Hypersensitivity

Very rare (less than 0.01%): Allergic reactions (including angioedema)[Ref]

Dermatologic

Very common (10% or more): Transient burning (about 23%), stinging (about 23%), tingling (about 23%), skin irritation (up to 15%), rash (11%)

Common (1% to 10%): Pruritus, dermatitis, contact dermatitis (including facial and perioral), dry skin, irritation, worsening of psoriasis, erythema, peeling

Uncommon (0.1% to 1%): Skin atrophy, hyperpigmentation, folliculitis, eczema

Frequency not reported: Transient changes in skin pigmentation, transient photosensitivity, urticaria, angioedema, skin exfoliation[Ref]

Metabolic

Uncommon (0.1% to 1%): Hypercalcemia

Rare (less than 0.1%): Transient increases in serum calcium

Very rare (less than 0.01%): Hypercalcemia, hypercalciuria (especially if the total recommended dose is exceeded)[Ref]

Local

Very common (10% or more): Lesional/perilesional irritation (up to 39%), face and/or scalp irritation (up to 25%)[Ref]

Other

Frequency not reported: Periorbital or face edema[Ref]

Frequently asked questions

References

1. Product Information. Dovonex (calcipotriene topical). Westwood Squibb Pharmaceutical Corporation. PROD.

2. Cerner Multum, Inc. UK Summary of Product Characteristics.

3. Cerner Multum, Inc. Australian Product Information.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.